Skip to main content
SpringerLink
Log in

Einfluss von Dosis und Fraktionierung auf die kurativ intendierte Strahlentherapie nicht-kleinzelliger Bronchialkarzinome

Influence of dose and fractionation in radiation therapy of curative intent for non-small cell lung cancer

  • Literatur kommentiert
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Baker S, Dahele M, Lagerwaard FJ, Senan S (2016) A critical review of recent developments in radiotherapy for non-small cell lung cancer. Radiat Oncol 11:115. doi:10.1186/s13014-016-0693-8

    Article  PubMed  PubMed Central  Google Scholar 

  2. Guckenberger M, Kavanagh A, Partridge M (2012) Combining advanced radiotherapy technologies to maximize safety and tumor control probability in stage III non-small cell lung cancer. Strahlenther Onkol 188:894–900

    Article  CAS  PubMed  Google Scholar 

  3. Ramroth J, Cutter DJ, Darby SCJ et al (2016) Dose and fractionation in radiation therapy of curative intent for non-small cell lung cancer: meta-analysis of randomized trials. Int J Radiat Oncol Biol Phys 96:736–747

    Article  PubMed  PubMed Central  Google Scholar 

  4. Bradley JD, Paulus R, Komaki R et al (2015) Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol 16:187–199

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Willner J, Baier K, Caragiani E et al (2002) Dose, volume, and tumor control prediction in primary radiotherapy of non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 52:382–389

    Article  PubMed  Google Scholar 

  6. Nyman J, Hallqvist A, Lund JÅ et al (2016) SPACE – A randomized study of SBRTvs conventional fractionated radiotherapy in medically inoperable stage I NSCLC. Radiother Oncol 121:1–8

    Article  PubMed  Google Scholar 

  7. De Ruysscher D, Wanders R, van Haren E et al (2008) HI-CHART: a phase I/II study on the feasibility of high-dose continuous hyperfractionated accelerated radiotherapy in patients with inoperable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 71:132–138

    Article  PubMed  Google Scholar 

  8. Chen M, Hayman JA, Ten Haken RK et al (2006) Long-term results of high-dose conformal radiotherapy for patients with medically inoperable T1-3N0 non-small-cell lung cancer: is low incidence of regional failure due to incidental nodal irradiation? Int J Radiat Oncol Biol Phys 64:120–126

    Article  PubMed  Google Scholar 

  9. Zhao J, Xia Y, Kaminski J et al (2016) Treatment-related death during concurrent chemoradiotherapy for locally advanced non-small cell lung cancer: a meta-analysis of randomized studies. PLOS ONE 11:e0157455

    Article  PubMed  PubMed Central  Google Scholar 

  10. Zschaeck S, Simon M, Löck S et al (2016) PRONTOX – proton therapy to reduce acute normal tissue toxicity in locally advanced non-small-cell lung carcinomas (NSCLC): study protocol for a randomised controlled trial. Trials 17:543

    Article  PubMed  PubMed Central  Google Scholar 

  11. Brower JV, Amini A, Chen S et al (2016) Improved survival with dose-escalated radiotherapy in stage III non-small-cell lung cancer: analysis of the National Cancer Database. Ann Oncol 27:1887–1894

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept. of Oncology and Palliative Medicine, Nordland Hospital Trust, Prinsensgate 164, 1480, 8092, Bodø, Norwegen

    Carsten Nieder

Authors
  1. Carsten Nieder
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carsten Nieder.

Ethics declarations

Interessenkonflikt

C. Nieder gibt an, dass kein Interessenkonflikt besteht.

Additional information

Originalpublikation Ramroth J, Cutter DJ, Darby SC et al (2016) Dose and fractionation in radiation therapy of curative intent for non-small cell lung cancer: meta-analysis of randomized trials. Int J Radiat Oncol Biol Phys 96:736–747

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nieder, C. Einfluss von Dosis und Fraktionierung auf die kurativ intendierte Strahlentherapie nicht-kleinzelliger Bronchialkarzinome. Strahlenther Onkol 193, 240–242 (2017). https://doi.org/10.1007/s00066-017-1096-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-017-1096-y

Search

Navigation